Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/8/25 16:30 | 7/3/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Kelly John Alexander | NC | O | CFO | 1 | S | -63 | 4.26 | 0 | -15 | 73 | D | |||||||||||||||
3/25/25 18:00 | 3/24/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Amoroso Michael | NC | DO | P,CEO | 4 | S.d | -218 | 5.14 | 0 | -42 | 110 | D | |||||||||||||||
3/5/25 19:00 | 3/4/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Smith J. Jefferson | NC | O | Chief Re | 4 | S.d | -52 | 4.90 | 0 | -11 | 96 | D | |||||||||||||||
3/5/25 19:00 | 3/4/25 | DTIL | Health | BioPrd | Biological Products, (No Diag | Scimeca Dario | NC | O | GC,Secre | 5 | S.d | -53 | 5.20 | 0 | -10 | 25 | D | |||||||||||||||
5/3/24 18:30 | 5/2/24 | DTIL | Health | BioPrd | Biological Products, (No Diag | List Alan | NC | O | Chief Me | 2 | S.d | -5 | 10.19 | 0 | -1 | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |